India  

Covaxin does not contain newborn calf serum, say Bharat Biotech and govt

IndiaTimes Wednesday, 16 June 2021
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

Covaxin output set to rise; govt hopes to meet 135 crore-dose goal

Indian Immunologicals Limited is likely to start supply of an additional 2 million doses of Covaxin from August-September, whereas Bharat Biotech’s Ankleshwar..
IndiaTimes
Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News [Video]

Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News

Top political leaders today expressed anguish over the allegedrape and murderof a nine-year-old Dalit girl in the Delhi Cantonment area on Sunday. The government has said today that the pandemic is still raging in the country and eight states have shown a rise in the R-factor, calling it a significant problem. The monthly production capacity of Covishield is projected to be increased to more than 120 million doses and of Covaxin to around 58 million doses by December, the government told Rajya Sabha today, citing information from the COVID-19 vaccine manufacturers. The United Arab Emirates will lift a ban on transit passenger traffic from India, Pakistan, Nigeria and other countries from August 5, the country's National Emergency and Crisis Management Authority said on Tuesday. #Covid19 #Coronavirus #DalitGirlRape

Credit: Oneindia    Duration: 03:00Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
IndiaTimes

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
IndiaTimes
PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News [Video]

PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News

Today, the Monsoon session of the Lok Sabha began on a chaotic note with the opposition preventing Prime Minister Narendra Modi from introducing his newly-inducted Union ministers to the House; The second dose of Bharat Biotech's Covaxin for children aged 2-6 years, is likely to be administered to those participating in the trials next week; Amid the ongoing military standoff with China in eastern Ladakh, Indian agencies are closely monitoring the development of a Chinese airbase in Shakche; Today, Delhi Chief Minister Arvind Kejriwal said that a 'world-class drainage system' will be developed across the national capital. #MonsoonSession #Opposition #PMModi

Credit: Oneindia    Duration: 02:22Published

Related videos from verified sources

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News [Video]

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine ZyCov-D. An approval for Zydus' vaccine, would make it..

Credit: Oneindia     Duration: 02:09Published

Related news from verified sources

Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 cror

Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 cror
The Department of Biotechnology has given permission to HBPCL for producing Covaxin under Mission Covid Suraksha. Covaxin has been developed by Bharat Biotech in...
Mid-Day

Good immune response from Covishield & Covaxin: Study

A ‘real-world’ study of vaccinated healthcare workers has found Covishield and Covaxin could produce a high immune response in up to 95% recipients and...
IndiaTimes

Brazil regulator grants GMP certification to Bharat Biotech's Covaxin facilities

Less than a week after Brazil’s health regulator green-lighted the “exceptional import” of 4 million doses of Bharat Biotech’s Covid-19 jab Covaxin, it...
IndiaTimes